DE69024382D1 - Fledermausspeichel-Plasminogenaktivator vPA-alpha 1 - Google Patents

Fledermausspeichel-Plasminogenaktivator vPA-alpha 1

Info

Publication number
DE69024382D1
DE69024382D1 DE69024382T DE69024382T DE69024382D1 DE 69024382 D1 DE69024382 D1 DE 69024382D1 DE 69024382 T DE69024382 T DE 69024382T DE 69024382 T DE69024382 T DE 69024382T DE 69024382 D1 DE69024382 D1 DE 69024382D1
Authority
DE
Germany
Prior art keywords
vpa
alpha
plasminogen activator
bat saliva
saliva plasminogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69024382T
Other languages
English (en)
Other versions
DE69024382T2 (de
Inventor
Berthold Baldus
Peter Donner
Wolf-Dieter Schleuning
Alejandro Alagon
Werner Boidol
Joern Reiner Kraetzschmar
Bernhard Jacques Haendler
Gernot Langer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3904580A external-priority patent/DE3904580A1/de
Priority claimed from DE19893917949 external-priority patent/DE3917949A1/de
Application filed by Schering AG filed Critical Schering AG
Publication of DE69024382D1 publication Critical patent/DE69024382D1/de
Application granted granted Critical
Publication of DE69024382T2 publication Critical patent/DE69024382T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69024382T 1989-02-13 1990-02-13 Fledermausspeichel-Plasminogenaktivator vPA-alpha 1 Expired - Lifetime DE69024382T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3904580A DE3904580A1 (de) 1989-02-13 1989-02-13 Neues thrombolytikum
DE19893917949 DE3917949A1 (de) 1989-05-30 1989-05-30 Neues thrombolytikum

Publications (2)

Publication Number Publication Date
DE69024382D1 true DE69024382D1 (de) 1996-02-08
DE69024382T2 DE69024382T2 (de) 1996-08-14

Family

ID=25877826

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69024382T Expired - Lifetime DE69024382T2 (de) 1989-02-13 1990-02-13 Fledermausspeichel-Plasminogenaktivator vPA-alpha 1

Country Status (16)

Country Link
EP (1) EP0383417B1 (de)
JP (1) JP2904918B2 (de)
AT (1) ATE132187T1 (de)
AU (1) AU642404B2 (de)
BR (1) BR9007115A (de)
CA (1) CA2046632C (de)
DE (1) DE69024382T2 (de)
DK (1) DK0383417T3 (de)
ES (1) ES2085326T3 (de)
FI (1) FI103577B1 (de)
GR (1) GR3019328T3 (de)
HU (1) HU217219B (de)
IE (1) IE73229B1 (de)
NO (1) NO308708B1 (de)
UA (1) UA34415C2 (de)
WO (1) WO1990009438A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE69054B1 (en) * 1988-07-20 1996-08-07 Schering Ag Vampire bat salivary plasminogen activators
DE3943241A1 (de) * 1989-12-22 1991-06-27 Schering Ag Thrombolytisch wirkendes kombinationspraeparat
DE4442665A1 (de) * 1994-11-30 1996-06-05 Gruenenthal Gmbh Chimäre Proteine mit fibrinolytischen und thrombinhemmenden Eigenschaften
US5731186A (en) * 1996-02-05 1998-03-24 Schering Aktiengesellschaft Method for the production of rDSPA α1
DE10016139A1 (de) * 2000-03-27 2001-10-18 Schleuning Wolf Dieter Verfahren zur Bestimmung von löslichem Fibrin
DE10153601A1 (de) 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
JP4824565B2 (ja) * 2003-05-21 2011-11-30 アレス トレーディング ソシエテ アノニム タンパク質溶液のクロマトグラフィー分析の方法
DE10342518A1 (de) * 2003-09-12 2005-05-12 Paion Gmbh Plasminogen-Aktivatoren mit verringerter Lysin-Bindungskapazität
GB0321997D0 (en) 2003-09-19 2003-10-22 Novartis Ag Organic compound
DE202006015207U1 (de) * 2006-05-19 2007-08-16 Paion Deutschland Gmbh Verwendung vn Plasminogenaktivatoren zur Behandlung einer Venenthromboembolie
WO2008058736A1 (en) 2006-11-17 2008-05-22 Novartis Ag Lingo binding molecules and pharmaceutical use thereof
US8163285B2 (en) 2007-11-02 2012-04-24 Novartis Ag Nogo-A binding molecules and pharmaceutical use thereof
EP2558580A2 (de) 2010-04-16 2013-02-20 H. Lundbeck A/S Verfahren zur herstellung von rekombinantem dspa-alpha1
JP2022553300A (ja) 2019-10-24 2022-12-22 ノヴァゴー セラピューティクス アーゲー 新規抗Ｎｏｇｏ－Ａ抗体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE69054B1 (en) * 1988-07-20 1996-08-07 Schering Ag Vampire bat salivary plasminogen activators

Also Published As

Publication number Publication date
FI103577B (fi) 1999-07-30
FI913818A0 (fi) 1991-08-12
DK0383417T3 (da) 1996-05-13
IE73229B1 (en) 1997-05-21
EP0383417B1 (de) 1995-12-27
GR3019328T3 (en) 1996-06-30
HU217219B (hu) 1999-12-28
WO1990009438A1 (en) 1990-08-23
AU5080790A (en) 1990-09-05
FI103577B1 (fi) 1999-07-30
AU642404B2 (en) 1993-10-21
HUT59724A (en) 1992-06-29
NO308708B1 (no) 2000-10-16
JP2904918B2 (ja) 1999-06-14
EP0383417A1 (de) 1990-08-22
CA2046632A1 (en) 1990-08-14
ES2085326T3 (es) 1996-06-01
IE900506L (en) 1990-08-13
NO913129L (no) 1991-10-11
CA2046632C (en) 1999-05-11
DE69024382T2 (de) 1996-08-14
UA34415C2 (uk) 2001-03-15
JPH04504799A (ja) 1992-08-27
HU902004D0 (en) 1991-11-28
ATE132187T1 (de) 1996-01-15
NO913129D0 (no) 1991-08-12
BR9007115A (pt) 1991-11-26

Similar Documents

Publication Publication Date Title
ATE113846T1 (de) Therapeutische zusammensetzungen für die behandlung von myocard-infarkten.
FR13C0021I2 (fr) Conjugates d'exendin-4 et leur utilisation medicale
DE69024382D1 (de) Fledermausspeichel-Plasminogenaktivator vPA-alpha 1
NO885109D0 (no) FremgangsmŸte og middel for Ÿ forhindre blodpropp.
ATE358176T1 (de) Menschliche dnase
EP0787802A3 (de)
MX172600B (es) , "procedimiento para la produccion de una proteina biologicamente activa
DK0786257T3 (da) Glycolyseringsvarianter af vævsplasminogenaktivator med forbedrede terapeutiske egenskaber
IT1142032B (it) Preparato che favorisce la coagulazione del sangue a base di proteine umani, nonche' procedimento per la preparazione
IT8868118A0 (it) Composizione e procedimento per il trattamento e la cura dei capelli
PH25503A (en) Method of medical treatment
IT9041503A0 (it) Dispositivo per la cura chirurgica dell'ametropia
IT1238825B (it) Dispositivo per la correzione chirurgica dell'ametropia.
DE3780506D1 (de) Reinigung des einkettigen und zweikettigen gewebeplasminogenaktivators.
DE3751218T2 (de) Verfahren und therapeutische Zubereitungen für die Behandlung von Gerinnungsstörungen.
DE3780357D1 (de) Plasminogen-aktivator und thrombolytische zusammensetzung.
IT8919215A0 (it) Dispositivo per la cura chirurgica dell'ametropia.
DE68914886T2 (de) Mittel zur Behandlung von Raynaud's Krankheit.
NO880831D0 (no) Rekombinant human vevsplasminogen-aktivatorblanding.
DE322376T1 (de) Ausruestung fuer die sterilisierung und/oder spuelung von medizinischen, insbesondere zahnmedizinischen instrumenten.
DE3765614D1 (de) Augenchirurgisches instrument zum absaugen und spuelen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BAYER SCHERING PHARMA AG, 13353 BERLIN, DE

8327 Change in the person/name/address of the patent owner

Owner name: BAYER SCHERING PHARMA AKIENGESELLSCHAFT, 13353, DE